VYCOR MEDICAL INC (VYCO)

Every figure below is the company's own, as filed. Nothing is estimated and nothing is smoothed — a period the filing does not support is left blank rather than drawn. Quarters are the company's own, counted from its financial year ending 12-31. Amounts in USD.

Revenue Quarterly

0 200K 400K 600K Q3 '16: 325.8K Q4 '16: 347.4K Q1 '17: 428.4K Q2 '17: 307.7K Q3 '17: 379.1K Q4 '17: 269.8K Q1 '18: 325.1K Q2 '18: 301.7K Q3 '18: 456.2K Q4 '18: 426.4K Q1 '19: 350.7K Q2 '19: 411.9K Q3 '19: 322.9K Q4 '19: 331.5K Q1 '20: 330.2K Q2 '20: 244.3K Q3 '20: 275.9K Q4 '20: 291.6K Q1 '21: 295.7K Q2 '21: 491.4K Q3 '21: 332.1K Q4 '21: 273.7K Q1 '22: 313.8K Q2 '22: 327.9K Q3 '22: 310K Q4 '22: 271.3K Q1 '23: 361K Q2 '23: 482.8K Q3 '23: 308.6K Q4 '23: 308.2K Q1 '24: 337K Q2 '24: 406.3K Q3 '24: 390.9K Q4 '24: 455.2K Q1 '25: 436.4K Q2 '25: 496.4K Q3 '25: 513.8K Q4 '25: 416.9K Q1 '26: 458.5K Q2 '26: 418.3K Q3 '17 Q4 '18 Q1 '20 Q2 '21 Q3 '22 Q4 '23 Q1 '25 Q2 '26

Gross Profit Quarterly

0 200K 400K 600K Q3 '16: 288.3K Q4 '16: 315.6K Q1 '17: 380.4K Q2 '17: 268.2K Q3 '17: 323.7K Q4 '17: 185.4K Q1 '18: 295.8K Q2 '18: 254.7K Q3 '18: 409.4K Q4 '18: 379.9K Q1 '19: 314.5K Q2 '19: 375.8K Q3 '19: 293.9K Q4 '19: 294.2K Q1 '20: 292.9K Q2 '20: 223.8K Q3 '20: 235.4K Q4 '20: 257.5K Q1 '21: 267.3K Q2 '21: 452.1K Q3 '21: 296.9K Q4 '21: 241.9K Q1 '22: 280.4K Q2 '22: 300K Q3 '22: 267.8K Q4 '22: 234.1K Q1 '23: 330.2K Q2 '23: 443K Q3 '23: 276.3K Q4 '23: 266.2K Q1 '24: 300K Q2 '24: 371.1K Q3 '24: 354.1K Q4 '24: 397.4K Q1 '25: 358.5K Q2 '25: 415.3K Q3 '25: 451.9K Q4 '25: 335.4K Q1 '26: 375.2K Q2 '26: 344.4K Q3 '17 Q4 '18 Q1 '20 Q2 '21 Q3 '22 Q4 '23 Q1 '25 Q2 '26

Operating Income Quarterly

-600K -400K -200K 0 200K 400K 600K Q3 '16: -315.2K Q4 '16: -469.9K Q1 '17: -299.7K Q2 '17: -353.9K Q3 '17: -295.6K Q4 '17: -363.4K Q1 '18: -314.6K Q2 '18: -405.6K Q3 '18: -132.7K Q4 '18: -464.8K Q1 '19: -162.8K Q2 '19: -130.5K Q3 '19: -165.7K Q4 '19: -175.6K Q1 '20: -146.7K Q2 '20: -199.4K Q3 '20: -206.4K Q4 '20: -175K Q1 '21: -206.8K Q2 '21: 23.5K Q3 '21: -88.4K Q4 '21: -164.2K Q1 '22: -52.9K Q2 '22: -74.4K Q3 '22: -88K Q4 '22: -91.2K Q1 '23: 33.2K Q2 '23: 96.5K Q3 '23: -25.5K Q4 '23: -64.1K Q1 '24: -9.5K Q2 '24: 16.2K Q3 '24: -35.1K Q4 '24: 19.3K Q1 '25: -12.8K Q2 '25: 51.1K Q3 '25: 32.1K Q4 '25: -36.5K Q1 '26: 45.8K Q2 '26: 6.9K Q3 '17 Q4 '18 Q1 '20 Q2 '21 Q3 '22 Q4 '23 Q1 '25 Q2 '26

Net Income Quarterly

-600K -400K -200K 0 200K 400K 600K Q3 '16: -331.9K Q4 '16: -487.5K Q1 '17: -312.8K Q2 '17: -360.7K Q3 '17: -428.4K Q4 '17: -375.1K Q1 '18: -326.6K Q2 '18: -418.6K Q3 '18: -152.2K Q4 '18: -482K Q1 '19: -180.3K Q2 '19: -185.3K Q3 '19: -209.6K Q4 '19: -221K Q1 '20: -174.9K Q2 '20: -248.9K Q3 '20: -198.3K Q4 '20: -200.4K Q1 '21: -242.9K Q2 '21: -9.4K Q3 '21: 3.7K Q4 '21: -187.1K Q1 '22: -74.6K Q2 '22: -99K Q3 '22: -114.8K Q4 '22: -116.5K Q1 '23: 6.9K Q2 '23: 68.4K Q3 '23: -51.9K Q4 '23: -93.1K Q1 '24: -30.6K Q2 '24: -10K Q3 '24: -59.8K Q4 '24: -6.7K Q1 '25: -38.6K Q2 '25: 23.9K Q3 '25: 4.9K Q4 '25: -62.7K Q1 '26: 20.1K Q2 '26: -22.3K Q3 '17 Q4 '18 Q1 '20 Q2 '21 Q3 '22 Q4 '23 Q1 '25 Q2 '26

Cost of Revenue Quarterly

0 30K 60K 90K Q1 '17: 48K Q2 '17: 39.4K Q3 '17: 55.3K Q4 '17: 84.4K Q1 '18: 29.3K Q2 '18: 47K Q3 '18: 46.8K Q4 '18: 46.5K Q1 '19: 36.2K Q2 '19: 36.1K Q3 '19: 29K Q4 '19: 37.3K Q1 '20: 37.3K Q2 '20: 20.5K Q3 '20: 40.6K Q4 '20: 34.1K Q1 '21: 28.5K Q2 '21: 39.3K Q3 '21: 35.1K Q4 '21: 31.8K Q1 '22: 33.4K Q2 '22: 27.9K Q3 '22: 42.2K Q4 '22: 37.2K Q1 '23: 30.8K Q2 '23: 39.8K Q3 '23: 32.3K Q4 '23: 42K Q1 '24: 37K Q2 '24: 35.2K Q3 '24: 36.8K Q4 '24: 57.8K Q1 '25: 77.8K Q2 '25: 81.1K Q3 '25: 61.9K Q4 '25: 81.5K Q1 '26: 83.4K Q2 '26: 73.8K Q3 '17 Q4 '18 Q1 '20 Q2 '21 Q3 '22 Q4 '23 Q1 '25 Q2 '26

Operating Cash Flow Quarterly

-270K -180K -90K 0 90K 180K 270K Q2 '16: -182.8K Q3 '16: -2.8K Q4 '16: -111.2K Q1 '17: -242.8K Q2 '17: -6.7K Q3 '17: -101.7K Q4 '17: -176.2K Q1 '18: -144.7K Q2 '18: -105.4K Q3 '18: -36K Q4 '18: 25.8K Q1 '19: -18.1K Q2 '19: -12.3K Q3 '19: 19.6K Q4 '19: 4.8K Q1 '20: -34.6K Q2 '20: -44.5K Q3 '20: -163.7K Q4 '20: -5.9K Q1 '21: -34.2K Q2 '21: 86.5K Q3 '21: -62.4K Q4 '21: 31.5K Q1 '22: -78.8K Q2 '22: -28.1K Q3 '22: -76.7K Q4 '22: -33.4K Q1 '23: 24.6K Q2 '23: 14.2K Q3 '23: -14.9K Q4 '23: 5.5K Q1 '24: 1.9K Q2 '24: 86K Q3 '24: 10.5K Q1 '25: -26.9K Q2 '25: 46.6K Q3 '25: -72.4K Q4 '25: 39.2K Q1 '26: 99.4K Q2 '26: -4.8K Q2 '17 Q3 '18 Q4 '19 Q1 '21 Q2 '22 Q3 '23 Q1 '25 Q2 '26

Free Cash Flow Quarterly

-1.5M -1M -500K 0 500K 1M 1.5M Q1 '13: -273.8K Q2 '13: -297.4K Q3 '13: -171.6K Q4 '13: -115.4K Q1 '14: -1.2M Q2 '14: -668.8K Q3 '14: -373.2K Q4 '14: -601.6K Q1 '15: -514.4K Q2 '15: -264K Q3 '15: -342.8K Q4 '15: -256.4K Q1 '16: -217.3K Q2 '16: -185.9K Q3 '16: -10.8K Q4 '16: -140.4K Q1 '17: -314.1K Q2 '17: -23.4K Q3 '17: -174K Q4 '17: -199.2K Q1 '18: -157.9K Q2 '18: -142.2K Q3 '18: -42.6K Q4 '18: 18.9K Q1 '19: -24.4K Q2 '19: -13K Q3 '19: 3.7K Q4 '19: -26.6K Q1 '20: -81.2K Q2 '20: -47.9K Q3 '20: -173.9K Q4 '20: -7.8K Q1 '21: -58.1K Q2 '21: 78.2K Q3 '21: -68.8K Q4 '21: 31.1K Q3 '22: -76.8K Q4 '23: -396 Q3 '25: -72.4K Q4 '25: 37.6K Q1 '14 Q2 '15 Q3 '16 Q4 '17 Q1 '19 Q2 '20 Q3 '21 Q4 '25

Operating cash flow minus capital expenditure.

Shares Outstanding Quarterly

0 15M 30M 45M Q1 '21: 27.8M Q2 '21: 29.7M Q3 '21: 30.2M Q1 '22: 30.8M Q2 '22: 31.5M Q3 '22: 32M Q1 '23: 32.5M Q2 '23: 37.5M Q3 '23: 32.6M Q1 '24: 32.6M Q2 '24: 32.6M Q3 '24: 32.9M Q1 '25: 33.4M Q2 '25: 38.7M Q3 '25: 33.4M Q1 '26: 33.4M Q2 '26: 33.4M Q2 '21 Q2 '22 Q2 '23 Q2 '24 Q2 '25 Q2 '26

Weighted average diluted, as the filer reports it for each period. An average cannot be added across periods, so this one is always shown per period the filer tagged rather than as a trailing year.

EPS TTM

-1.50 -1.00 -0.50 0.00 0.50 1.00 1.50 Q3 '12: -1.34 Q4 '12: -0.52 Q1 '13: -0.49 Q2 '13: -0.45 Q3 '13: -0.39 Q4 '13: -0.39 Q1 '14: -0.37 Q2 '14: -0.39 Q3 '14: -0.43 Q4 '14: -0.39 Q1 '15: -0.37 Q2 '15: -0.29 Q3 '15: -0.22 Q4 '15: -0.19 Q1 '16: -0.18 Q2 '16: -0.17 Q3 '16: -0.16 Q4 '16: -0.18 Q1 '17: -0.15 Q2 '17: -0.14 Q3 '17: -0.13 Q4 '17: -0.10 Q1 '18: -0.09 Q2 '18: -0.09 Q3 '18: -0.07 Q4 '18: -0.07 Q1 '19: -0.06 Q2 '19: -0.05 Q3 '19: -0.06 Q4 '19: -0.05 Q1 '20: -0.05 Q2 '20: -0.05 Q3 '20: -0.04 Q4 '20: -0.03 Q1 '21: -0.03 Q2 '21: -0.02 Q1 '23: -0.01 Q2 '23: -0.01 Q1 '26: 0.00 Q2 '26: 0.00 Q3 '13 Q4 '14 Q1 '16 Q2 '17 Q3 '18 Q4 '19 Q1 '21 Q2 '26

The filer's own published earnings a share for each quarter, four quarters added up. The company page divides trailing net income by the share count instead, which lands within about 1% of this and is not the same sum, so the two are named differently rather than presented as one figure.